2008
DOI: 10.1157/13120053
|View full text |Cite
|
Sign up to set email alerts
|

Protocolo de uso de la tizanidina en la parálisis cerebral infantil

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2010
2010
2024
2024

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…However, the therapeutic effect is achieved only after the application of high doses. Serious adverse effects, especially after abrupt withdrawal, reduce its efficacy and safety in children with DV [64]. Therefore, tizanidine, a muscle relaxant used in many studies as a short-acting muscle relaxant due to spasmolytic action, was used.…”
Section: Muscle Relaxantsmentioning
confidence: 99%
“…However, the therapeutic effect is achieved only after the application of high doses. Serious adverse effects, especially after abrupt withdrawal, reduce its efficacy and safety in children with DV [64]. Therefore, tizanidine, a muscle relaxant used in many studies as a short-acting muscle relaxant due to spasmolytic action, was used.…”
Section: Muscle Relaxantsmentioning
confidence: 99%